Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, Wilson J M
Institute for Human Gene Therapy, Department of Medicine and Molecular and Cellular Engineering, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
J Clin Invest. 1998 Sep 1;102(5):874-80. doi: 10.1172/JCI2410.
Previous studies have implicated the novel peptide antibiotic human beta-defensin 1 (hBD-1) in the pathogenesis of cystic fibrosis. We describe in this report the isolation and characterization of the second member of this defensin family, human beta-defensin 2 (hBD-2). A cDNA for hBD-2 was identified by homology to hBD-1. hBD-2 is expressed diffusely throughout epithelia of many organs, including the lung, where it is found in the surface epithelia and serous cells of the submucosal glands. A specific antibody made of recombinant peptide detected hBD-2 in airway surface fluid of human lung. The fully processed peptide has broad antibacterial activity against many organisms, which is salt sensitive and synergistic with lysozyme and lactoferrin. These data suggest the existence of a family of beta-defensin molecules on mucosal surfaces that in the aggregate contributes to normal host defense.
先前的研究表明,新型肽抗生素人β-防御素1(hBD-1)与囊性纤维化的发病机制有关。我们在本报告中描述了该防御素家族第二个成员人β-防御素2(hBD-2)的分离和特性。通过与hBD-1的同源性鉴定出了hBD-2的cDNA。hBD-2在包括肺在内的许多器官的上皮中广泛表达,在肺中它存在于表面上皮和黏膜下腺的浆液细胞中。由重组肽制成的特异性抗体在人肺气道表面液中检测到了hBD-2。完全加工后的肽对许多生物体具有广泛的抗菌活性,这种活性对盐敏感,并且与溶菌酶和乳铁蛋白具有协同作用。这些数据表明,黏膜表面存在一个β-防御素分子家族,它们共同有助于正常的宿主防御。